Specifically, they shown the increase in the production of ROS and the inhibition of Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2), which results in cell death of cancer cells including cisplatin-resistant cells lines, but not of normal cells, suggesting a selective effect. Here, NFE2L2 is linked to cancer.